Bright Minds Biosciences Inc (NASDAQ:DRUG) shares are trading higher again after soaring last week. The company on Monday ...

After a nearly 15-fold rise in value in the previous session, shares of Bright Minds Biosciences (NASDAQ:DRUG) fell ~29% on ...

Bright Minds Biosciences (DRUG) announced that it is once again collaborating with Firefly Neuroscience (AIFF), an Artificial Intelligence ...

Bright Minds Biosciences (TSE:DRUG) has released an update. Bright Minds Biosciences is teaming up again with Firefly Neuroscience to analyze ...

Bright Minds Biosciences is working with Firefly Neuroscience, an AI healthcare company, to provide a full analysis of the electroencephalogram data in Bright Minds' Phase 2 clinical trial evaluating ...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR ...

Psychedelic drug company Bright Minds Biosciences Inc. (NASDAQ: DRUG) saw its stock rocket higher by 1,445% to close the day ...

It mirrors a similar move in August 2022, when the firm denied knowledge of material changes before quickly announcing a ...

Bright Minds Biosciences shares are moving higher on Friday. The company announced a $35 million non-brokered private ...

BMB-201 demonstrated dose-dependent efficacy in pain modelsBMB-201 demonstrated similar efficacy to morphine in several pain ...

Bright Minds Biosciences (DRUG) stock surged by ~48% in premarket trading after the company announced a $35M private placement mainly for R&D. Read more here.

Shares of Bright Minds Biosciences on Friday shot higher after pricing a $35 million private placement. The stock was up 70% at $36.86 in pre-market trading. The company said it has priced the private ...